In the United States alone, about 1 in 10 adults use these drugs regularly. Some well-known brands include Prilosec, Nexium, ...

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of ...

If you’ve been prescribed famotidine and you’re interested in taking Pepcid AC or Zantac 360 instead, talk with your doctor. They may prefer that you take one version instead of the other.

Safe alternatives to Zantac are available. The drug is one of several H2-receptor antagonists (H2RAs), including cimetidine (Tagamet) and famotidine (Pepcid).Testing does not show that these drugs ...

If you take OTC proton pump inhibitors (PPIs), you could be among the uncounted. Familiar brands include Prilosec (omeprazole ...

It’s now made with famotidine, the active ingredient in competitor Pepcid. Zantac is still one of the US’s leading heartburn treatments in a market that generated $14 billion in sales last year.

Sanofi has since returned Zantac to store shelves but without ranitidine. It is now made with famotidine, the active ingredient in competitor Pepcid. Originally Published: May 8, 2024 at 12:53 PM CDT ...

After the FDA recall, Sanofi won approval to return Zantac to US store shelves, but without ranitidine. It’s now made with famotidine, the active ingredient in competitor Pepcid, which is ...

Sanofi reintroduced Zantac without ranitidine and is now using famotidine. Market-moving news hits Benzinga Pro first—get a 30-minute edge and save 60% this 4th of July.

Sanofi has since returned Zantac to store shelves, but without ranitidine. It’s now made with famotidine, the active ingredient in competitor Pepcid. Zantac is the third leading antacid sold in ...

Pepcid AC and Zantac 360 are brand-name versions of this drug. These versions may be available over the counter as well as by prescription. Famotidine also comes in an injectable form, ...

Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.